Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Crit Care Med ; 49(5): 816-827, 2021 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-33590999

RESUMEN

OBJECTIVES: There is evidence that noninvasive ventilation decreases the need for invasive mechanical ventilation. However, children with pediatric acute respiratory distress syndrome who fail noninvasive ventilation may have worse outcomes than those who are intubated without exposure to noninvasive ventilation. Our objective was to evaluate the impact of preintubation noninvasive ventilation on children with pediatric acute respiratory distress syndrome. DESIGN: Secondary analysis of data from the Randomized Evaluation of Sedation Titration for Respiratory Failure trial. SETTING: Thirty-one PICUs in the United States. PATIENTS: Children 2 weeks to 17 years old with pediatric acute respiratory distress syndrome receiving invasive mechanical ventilation, excluding those admitted with tracheostomies. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 2,427 subjects receiving invasive mechanical ventilation, preintubation noninvasive ventilation was used in 995 (41%). Compared with subjects without preintubation noninvasive ventilation use, subjects with preintubation noninvasive ventilation use were more likely to have a history of seizures (10% vs 8%; p = 0.04) or cancer (11% vs 6%; p < 0.001) and have moderate or severe pediatric acute respiratory distress syndrome by the end of their first full day of invasive mechanical ventilation (68% vs 60%; p < 0.001). Adjusting for age, severity of illness on PICU admission, and baseline functional status, preintubation noninvasive ventilation use resulted in longer invasive mechanical ventilation duration (median 7.0 vs 6.0 d), longer PICU (10.8 vs 8.9 d), and hospital (17 vs 14 d) lengths of stay, and higher 28-day (5% vs 4%) and 90-day (8% vs 5%) inhospital mortalities (all comparisons p < 0.001). Longer duration of noninvasive ventilation before intubation was associated with worse outcomes. CONCLUSIONS: In children with pediatric acute respiratory distress syndrome, preintubation noninvasive ventilation use is associated with worse outcomes when compared with no preintubation noninvasive ventilation use. These data can be used to inform the design of clinical studies to evaluate best noninvasive ventilation practices in children with pediatric acute respiratory distress syndrome.


Asunto(s)
Intubación Intratraqueal/métodos , Ventilación no Invasiva/métodos , Síndrome de Dificultad Respiratoria/terapia , Índice de Severidad de la Enfermedad , Adolescente , Niño , Preescolar , Enfermedad Crítica/terapia , Femenino , Humanos , Lactante , Masculino
2.
J Pediatr Hematol Oncol ; 36(4): 305-7, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-23426003

RESUMEN

Cetuximab, a monoclonal antibody specific for epidermal growth factor receptor, is increasingly used off-label and in early-phase trials for pediatric malignancies. Here, we report a patient with metastatic medulloblastoma receiving therapy with cyclophosphamide, vinblastine, and cetuximab. During evaluation for possible seizures, he was noted to be severely hypocalcemic, hypokalemic, and hypomagnesemic, a consequence of the blockade of renal epidermal growth factor receptor expression. His symptoms rapidly abated with intravenous electrolyte repletion. This case highlights the clinical heterogeneity of tetany and the importance of careful laboratory screening for known adverse effects of chemotherapy, particularly when newer biological agents are used off-study in combination chemotherapeutic regimens.


Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Antineoplásicos/efectos adversos , Neoplasias Cerebelosas/tratamiento farmacológico , Electrólitos/administración & dosificación , Hipercalciuria , Meduloblastoma/tratamiento farmacológico , Nefrocalcinosis , Defectos Congénitos del Transporte Tubular Renal , Tetania/tratamiento farmacológico , Anticuerpos Monoclonales Humanizados/administración & dosificación , Antineoplásicos/administración & dosificación , Neoplasias Cerebelosas/patología , Cetuximab , Preescolar , Humanos , Hipercalciuria/inducido químicamente , Hipercalciuria/tratamiento farmacológico , Masculino , Meduloblastoma/patología , Metástasis de la Neoplasia , Nefrocalcinosis/inducido químicamente , Nefrocalcinosis/tratamiento farmacológico , Defectos Congénitos del Transporte Tubular Renal/inducido químicamente , Defectos Congénitos del Transporte Tubular Renal/tratamiento farmacológico , Convulsiones/inducido químicamente , Convulsiones/tratamiento farmacológico , Tetania/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA